24 мар. 2022 г. · Compared with aspirin, clopidogrel was associated with reductions in MACE and stroke (ischemic and hemorrhagic) following DAPT completion after PCI.

31 авг. 2024 г. · Aspirin monotherapy compared with clopidogrel monotherapy was associated with similar cardiovascular and bleeding outcomes beyond 1 month and up ... Abstract · Methods · Results · Discussion

Clopidogrel monotherapy following 1 month of DAPT was superior to aspirin monotherapy following 12 months of DAPT in terms of major cardiovascular events at ... Abstract · Methods · Results · Discussion

Clopidogrel had a modest superiority over aspirin in reducing the combined risk of ischemic stroke, MI, or vascular death. ... There were no major differences in ...

Compared with aspirin, clopidogrel was associated with reductions in MACE and stroke (ischemic and hemorrhagic) following DAPT completion after PCI.

11 янв. 2016 г. · After 12-month DAPT, clopidogrel monotherapy, when compared with aspirin monotherapy, might be associated with a reduced risk of recurrent ischemic events in ...

12 апр. 2023 г. · Clopidogrel could be considered over aspirin monotherapy regardless of the presence of diabetes in patients who have undergone coronary stenting.

By the 1-year landmark analysis, clopidogrel was numerically, but not significantly, superior to aspirin for cardiovascular events (6.79% and 8.68%, ...

7 нояб. 2022 г. · Long-term treatment with clopidogrel monotherapy leads to a consistent reduction in cardiovascular events compared with aspirin monotherapy.

19 мая 2021 г. · These findings suggest that clopidogrel monotherapy is both more effective and safer than low-dose aspirin in patients who have completed 6 to 18 months of ...